Table of Contents

company-logo

Egetis Therapeutics AB (publ), a pharmaceutical drug development company, focuses on projects in late-stage development for the treatment of serious rare/niche diseases with unmet medical needs in the orphan drug segment. Its products pipeline includes Aladote, a drug to reduce the risk of acute liver injury associated with acetaminophen/paracetamol poisoning, which is in phase IIb/III clinical trial; and Emcitate, a drug for the treatment of MCT8 deficiency, a rare inborn error of thyroid hormone signaling that is in phase IIb/III clinical trial. The company was formerly known as PledPharma AB (publ) and changed its name to Egetis Therapeutics AB (publ) in December 2020. Egetis Therapeutics AB (publ) was incorporated in 2006 and is based in Stockholm, Sweden.

Egetis Therapeutics Dividend Announcement

• Egetis Therapeutics does not currently offer dividends, we're keeping a close eye on its growth potential and financial developments.
• Stay tuned for updates on Egetis Therapeutics dividend policy and future announcements. In the meantime, explore other dividend-yielding opportunities on our website.

Egetis Therapeutics Dividend History

Egetis Therapeutics Dividend Yield

Egetis Therapeutics current trailing twelve-month (TTM) dividend yield is -%. Interested in purchasing Egetis Therapeutics stock? Use our calculator to estimate your expected dividend yield:

Egetis Therapeutics Financial Ratios

P/E ratio-5.74
PEG ratio0.11
P/B ratio5.76
ROE-73.50%
Payout ratio0.00%
Current ratio0.98
Quick ratio0.98
Cash Ratio0.78

Egetis Therapeutics Dividend FAQ

Does Egetis Therapeutics stock pay dividends?
Egetis Therapeutics does not currently pay dividends to its shareholders.
Has Egetis Therapeutics ever paid a dividend?
No, Egetis Therapeutics has no a history of paying dividends to its shareholders. Egetis Therapeutics is not known for its dividend payments.
Why doesn't Egetis Therapeutics pay dividends?
There are several potential reasons why Egetis Therapeutics would choose not to pay dividends to their shareholders:

1. Growth opportunities: Companies, especially in fast-growing industries like technology, reinvest earnings into expansion, R&D, or acquisitions to fuel future growth and increase company value.

2. Tax implications: Not paying dividends can reduce the tax burden on shareholders, who may prefer to defer taxes until selling shares and realizing capital gains.

3. Investor preferences: Some investors prefer companies to reinvest profits for higher long-term returns, particularly those seeking capital appreciation over income.

4. Capital allocation priorities: Companies may allocate cash to pay down debt, fund share buybacks, or invest in projects with higher returns than dividends.

5. Market expectations: In certain sectors, like technology, reinvesting profits for growth and innovation is often prioritized over distributing dividends to shareholders.
Will Egetis Therapeutics ever pay a dividend?
The decision for a company to pay dividends depends on various factors including its financial performance, growth prospects, capital allocation priorities, and shareholder preferences. While Egetis Therapeutics has not paid dividends historically and has instead focused on reinvesting its earnings for growth, it's ultimately up to the company's management and board of directors to decide whether to initiate a dividend policy in the future.
Is Egetis Therapeutics a dividend aristocrat?
Egetis Therapeutics is not considered a Dividend Aristocrat. The term "Dividend Aristocrat" is typically used to describe a company in the S&P 500 index that has increased its dividend payouts for at least 25 consecutive years.
Is Egetis Therapeutics a dividend king?
Egetis Therapeutics is not classified as a "Dividend King". A Dividend King is a company that has managed to increase its dividend payouts for 50 consecutive years or more, which is an even more selective group than the Dividend Aristocrats.
Is Egetis Therapeutics a dividend stock?
No, Egetis Therapeutics is not considered a dividend stock. A dividend stock is a stock of a company that regularly pays out dividends to its shareholders.
How to buy Egetis Therapeutics stocks?
To buy Egetis Therapeutics you need a brokerage account. Open an account with a reputable brokerage firm that offers access to the stock market. Consider factors such as fees and account minimums.

Place an order: Use the brokerage's trading platform to place an order to buy Egetis Therapeutics stock.

Remember that buying stocks involves risk, and it's important to carefully consider your investment goals, risk tolerance, and conduct thorough research before making any investment decisions.